Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics #00498

Submission Number:
00498
Commenter:
Jason Tewell
State:
California
Initiative Name:
Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics
When will the FTC address this issue in todays health care? Allowing CVS and Aetna to merge would only further cloud any transparency, and this merger should be highly scrutinized and hopefully blocked. Anytime the payor and the dispenser become one entity, then they have the ability to pay themselves much higher than they would a retail pharmacy like myself. The FTC main purpose is to prevent things like this from causing major damage financially to the Constituents.